Ditec effects on clinicofunctional status were investigated in 15 pati
ents with mild and moderate atopic bronchial asthma (ABA) aged 20-50 (
5 males and 10 females). A single ditec dose had a broncholytic effect
along die entire bronchial tree and reduced sensitivity to acetylchol
ine. Magnesium sulfate (a single dose 3 mmol Mg2+, pH 6.6, tile soluti
on osmolality 260 mmol/l) potentiated ditec action on nonspecific hype
rreactivity of the bronchial tree. Four-week ditec course induced no c
onsiderable changes hi bronchial permeability, but increased reversibi
lity of bronchial obstruction, inhibited sensitivity and response of t
he bronchial tree to acetylcholine. Course administration of ditec low
ered endobronchial concentration of histamine and lipid peroxidation i
ntensity showing antiallergic and antiinflammatory properties of the d
rug. Ditec is recommended for ABA and other asthma forms treatment as
a Safe and effective modality.